The effectiveness and safety of aripiprazole, bromocriptine, and cabergoline in the treatment of hyperprolactinemia: a systematic review and network meta-analysis

Kun Ma Linna Ma Tianjiao Huang Yue Wang Guanlan Zhong Cong Gao Zhiyu Zhou Jie Luo a Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing,Chinab Graduate School,Tianjin University of Traditional Chinese Medicine,Tianjin,Chinac First School of Clinical Medicine,Heilongjiang University of Chinese Medicine,Harbin,Heilongjiang,China
DOI: https://doi.org/10.1080/14740338.2024.2416918
2024-10-17
Expert Opinion on Drug Safety
Abstract:Objective To assess the efficacy and safety of aripiprazole, bromocriptine, and cabergoline in the treatment of hyperprolactinemia (HPRL) using network meta-analysis.
pharmacology & pharmacy
What problem does this paper attempt to address?